Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8167389rdf:typepubmed:Citationlld:pubmed
pubmed-article:8167389lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8167389lifeskim:mentionsumls-concept:C0011849lld:lifeskim
pubmed-article:8167389lifeskim:mentionsumls-concept:C0220911lld:lifeskim
pubmed-article:8167389lifeskim:mentionsumls-concept:C0036745lld:lifeskim
pubmed-article:8167389pubmed:issue1lld:pubmed
pubmed-article:8167389pubmed:dateCreated1994-6-1lld:pubmed
pubmed-article:8167389pubmed:abstractTextIn sera from 476 diabetic outpatients, positive reaction in the Fluorescent Treponemal Antibody-Absorption (FTA-Abs) test, a commonly used serological test for syphilis, was found in 36 of the patients. None of 100 healthy control subjects were positive in the FTA-Abs test. Additional treponemal and nontreponemal tests confirmed the diagnosis of syphilis in only three of the diabetic patients. In 10 of the 36 patients, the positive FTA-Abs reactivity appeared to be due to cross-reactivity between the treponemal antigen and Borrelia burgdorferi, which causes Lyme borreliosis. In the remaining 23 patients (5%), no other explanation for a false-positive FTA-Abs reactivity was found besides diabetes. Diabetic patients with false-positive FTA-Abs reactivity had similar degree of long-term metabolic control and prevalence of islet cell antibodies (ICA) as well as late diabetic complications as FTA-Abs negative diabetic patients, matched regarding to sex, age, type, and duration of diabetes. In conclusion, false-positive FTA-Abs reactivity is not rare in diabetic patients. The reason for this phenomenon is unknown, but could be a sign of autoimmunity of its own. Hence, in diabetic patients with FTA-Abs test indicating syphilis, the diagnosis must be verified with a combination of other tests.lld:pubmed
pubmed-article:8167389pubmed:languageenglld:pubmed
pubmed-article:8167389pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167389pubmed:citationSubsetIMlld:pubmed
pubmed-article:8167389pubmed:statusMEDLINElld:pubmed
pubmed-article:8167389pubmed:issn1056-8727lld:pubmed
pubmed-article:8167389pubmed:authorpubmed-author:CarlssonBBlld:pubmed
pubmed-article:8167389pubmed:authorpubmed-author:OstensonC GCGlld:pubmed
pubmed-article:8167389pubmed:authorpubmed-author:BraunerAAlld:pubmed
pubmed-article:8167389pubmed:authorpubmed-author:SundkvistGGlld:pubmed
pubmed-article:8167389pubmed:issnTypePrintlld:pubmed
pubmed-article:8167389pubmed:volume8lld:pubmed
pubmed-article:8167389pubmed:ownerNLMlld:pubmed
pubmed-article:8167389pubmed:authorsCompleteYlld:pubmed
pubmed-article:8167389pubmed:pagination57-62lld:pubmed
pubmed-article:8167389pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:meshHeadingpubmed-meshheading:8167389-...lld:pubmed
pubmed-article:8167389pubmed:articleTitleFalse-positive treponemal serology in patients with diabetes mellitus.lld:pubmed
pubmed-article:8167389pubmed:affiliationDepartment of Clinical Bacteriology, Stockholm County Council Central Microbiological Laboratory, Sweden.lld:pubmed
pubmed-article:8167389pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8167389pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8167389pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8167389lld:pubmed